Basel, Switzerland

Niko Schmiedeberg

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niko Schmiedeberg. Retrieved from https://idiyas.com/inventor/niko-schmiedeberg-3sjy02i0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niko Schmiedeberg: Innovator in Pharmaceutical Compounds

Introduction

Niko Schmiedeberg is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts.

Latest Patents

Niko holds a patent for a compound titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent reflects his expertise in creating novel pharmaceutical compounds that may have various applications in medicine. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.

Career Highlights

Niko is currently employed at Suzhou Novartis Technical Development Co., Ltd., where he continues to work on innovative projects that aim to improve healthcare outcomes. His role at such a prestigious company highlights his expertise and the value he brings to the pharmaceutical industry.

Collaborations

Throughout his career, Niko has collaborated with talented professionals, including Vincent Bordas and Jvan Brun. These collaborations have likely contributed to the success of his projects and the development of new ideas in the field.

Conclusion

Niko Schmiedeberg is a dedicated inventor whose work in pharmaceutical compounds has the potential to impact the industry significantly. His innovative spirit and collaborative efforts position him as a valuable contributor to the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…